Bookbuilding IPO | ₹29 Cr | Listed at NSE SME | Wed, Nov 13, 2024 - Mon, Nov 18, 2024
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
Onyx Biotec Limited peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Onyx Biotec Limited | 2.28 | 2.28 | 18.67 | 26.81 | 12.19 | 3.27 | |
| Suven Pharmaceuticals Limited | 11.80 | 11.80 | 375.82 | 83.92 | 14.64 | 2.64 | |
| JB Chemicals | 35.66 | 35.66 | 188.37 | 53.63 | 18.90 | 10.15 |
Source: All the financial information for listed industry peer mentioned above is sourced from the annual report of the relevant companies for Fiscal 2024, as available on the websites of the NSE and BSE.
Notes for peer group:
Onyx Biotec IPO Reviews, analysis and views by popular members.
| Review By | Apply | May Apply | Not Rated | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
